Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Medlab Clinical ( (AU:MDC) ) has provided an update.
Medlab Clinical Limited has announced details for its upcoming annual general meeting, scheduled for February 13, 2025, to be held in person at their Perth office. Shareholders are encouraged to submit their proxy voting instructions by February 11, 2025, either online, by mail, email, fax, or in person. This meeting is a significant event for stakeholders, providing an opportunity to engage with the company’s strategic direction and governance.
More about Medlab Clinical
Medlab Clinical Limited, operating under the ASX code MDC, is a company based in Perth, Western Australia. The company is involved in the pharmaceutical and healthcare industry, focusing on the development and commercialization of novel therapeutic products.
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $9.9M
For a thorough assessment of MDC stock, go to TipRanks’ Stock Analysis page.
